Stark & Stark is no longer accepting inquiries for this litigation. For an updated list of our current cases, visit our homepage.
Xarelto (rivaroxaban) is a blood thinner that was approved by the FDA in July 2011 to prevent strokes. In November 2011, the approval was expanded to any patients with atrial fibrillation (irregular heartbeat). Xarelto has been widely prescribed, with millions of people taking the medication since it entered the market.
Xarelto is marketed as an anticoagulant prescribed to reduce the risk of atrial fibrillation (AFib), stroke, deep-vein thrombosis (DVT), and pulmonary embolism (PE). It is manufactured in the United States by Bayer and Johnson & Johnson’s New Jersey-based division, Janssen Pharmaceuticals.
Marketing efforts claim that Xarelto is safer than warfarin, another anticoagulant but recent studies suggest otherwise. Bleeding risks and other side effects common to blood thinners were found to be nearly identical. One selling point put forth by the manufacturer for switching to Xarelto is that it does not require the frequent blood draws that Warfarin requires to ensure appropriate levels of the drug in the patient; however, experts have opined that is not accurate.
Since its approval, there have been numerous reports of increased risk of injury when taking Xarelto, including, but not limited to:
These events can be life threatening since, unlike warfarin, there is no approved antidote for Xarelto to stop the bleeding.
Stark & Stark’s Mass Tort team pursues claims against drug manufacturers so they can be held liable when the drugs they market are proven to be defective and cause injury to the people who use them. Our Xarelto lawsuit lawyers are experienced in mass torts MDL litigation cases and in negotiating with pharmaceutical settlement representatives. If you or a member of your family has suffered an injury from Xarelto use, you may be entitled to compensation under the MDL litigation process or via settlement.
Please contact Stark & Stark to speak with one of the Xarelto attorneys, free of charge, who can help assess any claims that you may have and to help you understand the settlement and lawsuit process.
Stark & Stark Recognized with Community Partner Award by Mercer County Community College Foundation
Stark & Stark is proud to announce that the firm has been recognized with the Community Partner Award by the Mercer County Community College...Carin A. O’Donnell, Esq. Inducted as 2026-2027 President of the Pennsylvania Association for Justice
Stark & Stark is proud to announce that Carin A. O'Donnell, Esq. was sworn in as the 2026-2027 President of the Pennsylvania Association for...Stark & Stark’s Thomas S. Onder, Esq. Receives 2026 ICSC Trustees’ Distinguished Service Award
Stark & Stark is proud to announce that Thomas S. Onder, Esq., Shareholder and Chair of the Firm’s Shopping Center & Retail Development...Our Values Remain: A Message on the Closing of Diversity Lab
Stark & Stark is saddened and disappointed to learn that Diversity Lab, the organization that created and manages the Mansfield Certification...Retail Development Team Secures Major Recovery for Landlord Client Amid Bankruptcy Dispute
Our Shopping Center and Retail Development Group recently secured a multi-million-dollar settlement for a commercial landlord client' s property...